FDA Inspection
Novo Nordisk A/S - G8, X9 M.FINovo Nordisk A/S - G8, X9 M.FI – FDA Inspection, Apr 17, 2026
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - G8, X9 M.FI, with an inspection on April 17, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · db3fab11-abbb-487e-b474-adf67f6e209f
Inspection Facts
- Inspection number
- 1316850
- FDA center
- Human Drugs
Other FDA inspections of Novo Nordisk A/S - G8, X9 M.FI
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S - G8, X9 M.FI
- FDA Inspection 1297668 - 2022-06-16
- FDA Inspection 1210000 - 2021-05-12
- FDA Inspection 1057701 - 2018-06-01
- FDA Inspection 965339 - 2016-04-14
- FDA Inspection 874067 - 2014-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.